Parker, Kathrine
Hamilton, Patrick
Hanumapura, Prasanna
Castelino, Laveena
Murphy, Michelle
Challiner, Rachael
Thachil, Jecko
Ebah, Leonard
Article History
Received: 23 December 2020
Accepted: 26 April 2021
First Online: 16 June 2021
Declarations
:
: The Health Research Authority (HRA) and Medical Research Council decision tool (ExternalRef removed) was used to determine if NHS Research Ethics Committee (REC) review was required for the study. This tool does not deem this work as research and does not require this work to undergo formal NHS REC review, but it does necessitate consultation with the local research and development department. After review by Manchester University NHS Foundation Trust’s research and innovation department this work was classed as a retrospective audit and they deemed there was no requirement for informed consent.All patients’ information was anonymised for analysis and reporting.
: As this work was classed as a retrospective audit no formal consent was required. All data is anonymised for publication.
: None of the authors have relevant conflicts for present work.Within the last 3 years K Parker has received honoraria from Bayer. J Thachil has received honoraria from Bayer, Boehringer Ingelheim, BMS-Pfizer, Daichi-Sankyo, Octapharma, Leo Pharma.